0000899243-22-007483.txt : 20220223
0000899243-22-007483.hdr.sgml : 20220223
20220223192224
ACCESSION NUMBER: 0000899243-22-007483
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220220
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giffin Brett A.
CENTRAL INDEX KEY: 0001892921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 22665776
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-20
0
0001492674
T2 Biosystems, Inc.
TTOO
0001892921
Giffin Brett A.
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Commercial Officer
Restricted Stock Units
2022-02-20
4
A
0
200000
0.00
A
Common Stock
200000
200000
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units vest in three equal annual installments commencing on February 20, 2023.
/s/ John Sprague, Attorney-in-fact
2022-02-23